Outcomes in PIC-Related CNV: Pooled Analysis of Individual Participant Data

References

• Ahnood D, Madhusudhan S, Tsaloumas MD, Waheed NK, Keane PA, Denniston AK. Punctate inner choroidopathy: a review. Surv Ophthalmol. 2017 Mar;62(2):113–126. doi:10.1016/j.survophthal.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Gilbert RM, Niederer RL, Kramer M, et al. Differentiating multifocal choroiditis and punctate inner choroidopathy: a cluster analysis approach. Am J Ophthalmol. May 2020;213:244–251. doi:10.1016/j.ajo.2020.01.031.
   PubMed Web of Science ®Google Scholar
• Gerstenblith AT, Thorne JE, Sobrin L, et al. Punctate inner choroidopathy. Ophthalmology. Jun 2007;114(6):1201–1204.e4. doi:10.1016/j.ophtha.2006.10.047.
   PubMed Web of Science ®Google Scholar
• Essex RW. Punctate inner choroidopathy: clinical features and outcomes. Arch Ophthalmol. 2010 Aug 1;128(8):982. doi:10.1001/archophthalmol.2010.157.
   PubMedGoogle Scholar
• Niederer RL, Gilbert R, Lightman SL, Tomkins-Netzer O. Risk factors for developing choroidal neovascular membrane and visual loss in punctate inner choroidopathy. Ophthalmology. 2018 Feb;125(2):288–294. doi:10.1016/j.ophtha.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Pohlmann D, Pleyer U, Joussen AM, Winterhalter S. Optical coherence tomography angiography in comparison with other multimodal imaging techniques in punctate inner choroidopathy. Br J Ophthalmol. 2019 Jan;103(1):60–66. doi:10.1136/bjophthalmol-2017-311764.
   PubMed Web of Science ®Google Scholar
• Baxter SL, Pistilli M, Pujari SS, et al. risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. Sep 2013;156(3):468–477.e2. doi:10.1016/j.ajo.2013.04.040.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Invernizzi A, Singh RB, et al. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. Dec 2018;8(1):13. doi:10.1186/s12348-018-0155-6.
   PubMed Web of Science ®Google Scholar
• Tsaousis KT, Nassr M, Kapoor B, Konidaris VE, Tyradellis S, Empeslidis T. Long-term results of intravitreal bevacizumab and dexamethasone for the treatment of punctate inner choroidopathy associated with choroidal neovascularization: a case series. SAGE Open Med Case Rep. 2018 Jan 1;6:2050313X1877247. doi:10.1177/2050313X18772478.
   Web of Science ®Google Scholar
• Cornish KS, Williams GJ, Gavin MP, Imhe FR. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy. Eur J Ophthalmol. 2011 Jul;21(4):440–445. doi:10.5301/EJO.2010.6117.
   PubMed Web of Science ®Google Scholar
• Coco RM, de Souza CF, Sanabria MR. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm. 2007 Jan;15(1):27–29. doi:10.1080/09273940601174020.
   PubMed Web of Science ®Google Scholar
• Pohlmann D, Pleyer U, Joussen AM, Winterhalter S. Immunosuppressants and/or antivascular endothelial growth factor inhibitors in punctate inner choroidopathy?Follow-up results with optical coherence tomography angiography. Br J Ophthalmol. 2019 Aug;103(8):1152–1157. doi:10.1136/bjophthalmol-2018-312455.
   PubMed Web of Science ®Google Scholar
• Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA. Apr 28 2015;313(16):1657. doi:10.1001/jama.2015.3656.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Brezin AP, Levinson RD, et al. Classification criteria for punctate inner choroiditis. Am J Ophthalmol. 2021 Aug;228:275–280. DOI:10.1016/j.ajo.2021.03.046.
   PubMed Web of Science ®Google Scholar
• Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid-Based Med. 2018 Apr;23(2):60–63. doi:10.1136/bmjebm-2017-110853.
   PubMedGoogle Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Investig Ophthalmol Vis Sci. 2006 Mar 1;47(3):1236. doi:10.1167/iovs.05-0981.
   PubMed Web of Science ®Google Scholar
• Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry. Apr 2018;89(4):346–351. doi:10.1136/jnnp-2017-316286.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the first international workshop. Am J Ophthalmol. Sep 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med. 2017 Feb 28;36(5):855–875. doi:10.1002/sim.7141.
   PubMed Web of Science ®Google Scholar
• Barth T, Zeman F, Helbig H, Gamulescu MA. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy. Int Ophthalmol. 2018 Jun;38(3):923–931. doi:10.1007/s10792-017-0536-0.
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhang X, Mi L, et al. Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy. BMC Ophthalmol. Dec 2017;17(1):87. doi:10.1186/s12886-017-0481-8.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee SC, Park SJ, Lee CS. punctate inner choroidopathy and choroidal neovascularization in Korean patients. Ocul Immunol Inflamm. 2020 Jan 2;28(1):14–19. doi:10.1080/09273948.2018.1489060.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wen F, Zuo C, et al. Clinical features of punctate inner choroidopathy in Chinese patients. Retina. Sep 2011;31(8):1680–1691. doi:10.1097/IAE.0b013e31820a67ad.
   PubMed Web of Science ®Google Scholar
• Menezo V, Cuthbertson F, Downes SM. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina. 2010 Oct;30(9):1400–1404. doi:10.1097/IAE.0b013e3181d374dc.
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye. 1998 Mar;12(2):266–272. doi:10.1038/eye.1998.62.
   PubMed Web of Science ®Google Scholar
• Brouzas D, Charakidas A, Rotsos T, et al. Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature. Clin Ophthalmol. 2010 Jul;4:871–876.
   PubMedGoogle Scholar
• Amer R, Priel E, Kramer M. Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):949–957. doi:10.1007/s00417-015-2930-5.
   PubMed Web of Science ®Google Scholar
• Fong K, Thomas D, Amin K, Inzerillo D, Horgan S. Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. British Journal of Anaesthesia. 2010;105(1):6. doi:10.1093/bja/aeq139.
   PubMedGoogle Scholar
• Kongwattananon W, Grasic D, Lin H, Oyeniran E, Sen HN, Kodati S. Role of optical coherence tomography angiography in detecting and monitoring inflammatory choroidal neovascularization. Retina. 2022 Jun;42(6):1047–1056. doi:10.1097/IAE.0000000000003420.
   PubMed Web of Science ®Google Scholar
• Mangat SS, Ramasamy B, Prasad S, Walters G, Mohammed M, Mckibbin M. Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series. Semin Ophthalmol. 2011 Jan;26(1):1–3. doi:10.3109/08820538.2010.541322.
   PubMed Web of Science ®Google Scholar
• Chan WM, Lai TYY, Lau TTY, Lee VYW, Liu DTL, Lam DSC. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina. 2008 Jan;28(1):71–80. doi:10.1097/IAE.0b013e31815e9339.
   PubMed Web of Science ®Google Scholar
• Chan WM, Lai TYY, Liu DTL, Lam DSC. Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol. 2007 Jun;143(6):977–983.e1. doi:10.1016/j.ajo.2007.02.039.
   PubMed Web of Science ®Google Scholar
• Leslie T. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol. 2005 Feb 1;89(2):147–150. doi:10.1136/bjo.2004.046623.
   PubMed Web of Science ®Google Scholar
• Mansour A, Mackensen F, Khairallah, Mahendradas, Lai T, Bashshur. Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization. Clin Ophthalmol. 2012 Aug:1233. doi:10.2147/OPTH.S34294.
   PubMedGoogle Scholar
• Sim DA, Sheth HG, Kaines A, Tufail A. Punctate inner choroidopathy-associated choroidal neovascular membranes during pregnancy. Eye. 2008 May;22(5):725–727. doi:10.1038/eye.2008.93.
   PubMed Web of Science ®Google Scholar
• Haas AM, Stattin M, Ahmed D, Krebs I, Ansari-Shahrezaei S. Development of secondary choroidal neovascularization in focal choroidal excavation of punctate inner choroidopathy. Ocul Immunol Inflamm. 2020 Jan 2;28(1):20–25. doi:10.1080/09273948.2018.1540708.
   PubMed Web of Science ®Google Scholar
• Nakao S, Kaizu Y, Oshima Y, Sakamoto T, Ishibashi T, hei SK. Optical coherence tomography angiography for detecting choroidal neovascularization secondary to punctate inner choroidopathy. Ophthalmic Surg Lasers Imaging Retina. 2016 Dec;47(12):1157–1161. doi:10.3928/23258160-20161130-13.
   PubMed Web of Science ®Google Scholar
• Barth T, Zeman F, Helbig H, Oberacher-Velten I. Etiology and treatment of choroidal neovascularization in Pediatric patients. Eur J Ophthalmol. 2016 Sep;26(5):388–393. doi:10.5301/ejo.5000820.
   PubMed Web of Science ®Google Scholar
• Erol MK, Ozdemir O, Coban DT, Ceran BB, Bulut M. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity. Semin Ophthalmol. 2014 Mar;29(2):108–113. doi:10.3109/08820538.2013.839716.
   PubMed Web of Science ®Google Scholar
• Cornish KS, Lim LT, Imrie F. Management of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT) − A holistic approach. Semin Ophthalmol. 2012 Mar;27(1–2):29–32. doi:10.3109/08820538.2011.622334.
   PubMed Web of Science ®Google Scholar
• Rao VG, Rao GS, Narkhede NS. Flare up of choroiditis and choroidal neovasculazation associated with punctate inner choroidopathy during early pregnancy. Indian J Ophthalmol. 2011;59(2):145–158.
   PubMed Web of Science ®Google Scholar
• Tarantola RM, Folk JC, Boldt HC, Mahajan VB. Intravitreal bevacizumab during pregnancy. Retina. 2010 Oct;30(9):1405–1411. doi:10.1097/IAE.0b013e3181f57d58.
   PubMed Web of Science ®Google Scholar
• Leung AK, Weisbrod DJ, Schwartz C. Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Can J Ophthalmol. 2010 Jun;45(3):300–301. doi:10.3129/i09-253.
   PubMed Web of Science ®Google Scholar
• Caramoy A, Kirchhof B, Fauser S. Einseitiges Verzerrtsehen bei einer jungen Patientin. Ophthalmol. 2010 May;107(5):468–470. doi:10.1007/s00347-010-2133-8.
   Google Scholar
• Zagajewska K, Terelak-Borys B, Jankowska-Lech I, Tesla P, Grabska-Liberek I. Combined treatment in punctate inner choroidopathy. Ther Clin Risk Manag. Sep 2016;12:1467–1471. doi:10.2147/TCRM.S110556.
   PubMed Web of Science ®Google Scholar
• Rosen E, Rubowitz A, Ferencz JR. Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy. Eye. 2009 Jun;23(6):1479. doi:10.1038/eye.2008.218.
   PubMed Web of Science ®Google Scholar
• Vossmerbaeumer U, Spandau UH, V Baltz S, Wickenhaeuser A, Jonas JB. Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Exp Ophthalmol. 2008 Apr;36(3):292–294. doi:10.1111/j.1442-9071.2008.01727.x.
   PubMed Web of Science ®Google Scholar
• Levy J, Shneck M, Klemperer I, Lifshitz T. Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol. 2005 Nov;40(5):605–608. doi:10.1016/S0008-4182(05)80053-5.
   PubMed Web of Science ®Google Scholar
• Stattin M, Forster J, Ahmed D, Krepler K, Ansari-Shahrezaei S. Swept source-optical coherence tomography angiography for management of secondary choroidal neovascularization in punctate inner choroidopathy. Case Rep Ophthalmol. 2021 Apr 12;12(1):232–238. doi:10.1159/000511669.
   PubMed Web of Science ®Google Scholar
• Arrevola L, Acero MA, Peral MJ. Two-year outcome of aflibercept for the treatment of choroidal neovascularization in punctate inner choroidopathy. Case Rep Ophthalmol. 2019 Jan 24;10(1):24–31. doi:10.1159/000496143.
   PubMed Web of Science ®Google Scholar
• Hohberger B, Rudolph M, Bergua A. Choroidal neovascularization associated with punctate inner choroidopathy: combination of intravitreal anti-VEGF and systemic immunosuppressive therapy. Case Rep Ophthalmol. 2015 Nov 27;6(3):385–389. doi:10.1159/000441694.
   PubMedGoogle Scholar
• Campos J, Campos A, Beselga D, Mendes S, Neves A, Sousa JPC. punctate inner choroidopathy: a clinical case report. Case Rep Ophthalmol. 2013 Sep 28;4(3):155–159. doi:10.1159/000355389.
   PubMedGoogle Scholar
• Stepien KE, Carroll J. Using spectral-domain optical coherence tomography to follow outer retinal structure changes in a patient with recurrent punctate inner choroidopathy. J Ophthalmol. 2011;2011:1–3. doi:10.1155/2011/753741.
   Web of Science ®Google Scholar
• Holekamp NM, Thomas MA, Pearson A. The safety profile of long-term, high-dose intraocular corticosteroid delivery. Am J Ophthalmol. 2005 Mar;139(3):421–428. doi:10.1016/j.ajo.2004.10.005.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Gibson J. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol. 2003;87(7):925–927. doi:10.1136/bjo.87.7.925-a.
   PubMed Web of Science ®Google Scholar
• Roca M, Menezo M, Ronchera J, Esteban J, Roca B. Punctate inner choroidopathy complicated with exudative neurosensory detachment: a favourable response to treatment with systemic corticosteroids and intravitreal ranibizumab. Arch Soc Esp Oftalmol. 2017;92(7):343–346. doi:10.1016/j.oftal.2016.07.010.
   PubMedGoogle Scholar
• Jimenez B, Pinilla I, Cristobal J, et al. Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy. Arch Soc Esp Oftalmol. 2014;89(3):130–132. doi:10.1016/j.oftal.2012.11.008.
   PubMedGoogle Scholar
• Valverde Megías A, Arriola Villalobos P, Reche Frutos J, Donate López J, Calvo González C, García Feijoo J. Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Arch Soc Esp Oftalmol Engl Ed. 2010 Jan;85(4):149–152. doi:10.1016/S0365-6691(10)70039-3.
   PubMedGoogle Scholar
• Lim JI, Flaxel CJ, LaBree L. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singap. 2006;35(3):198–202.
   PubMed Web of Science ®Google Scholar
• Wu W, Li S, Xu H, et al. Treatment of punctate inner choroidopathy with choroidal neovascularization using corticosteroid and intravitreal ranibizumab. BioMed Res Int. 2018 Sep 13;2018:1–7.
   Web of Science ®Google Scholar
• Mansour AM, Arevalo JF, Fardeau C, et al. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol. Jun 2012;47(3):269–274. doi:10.1016/j.jcjo.2012.03.042.
   PubMed Web of Science ®Google Scholar
• Leung TG, Moradi A, Liu D, et al. Clinical features and incidence rate of ocular complications in punctate inner choroidopathy. Retina. Aug 2014;34(8):1666–1674. doi:10.1097/IAE.0000000000000125.
   PubMed Web of Science ®Google Scholar
• Gan Y, Zhang X, Chen L, Wen F. Intraretinal cystoid spaces in regression of punctate inner choroidopathy lesions. Ocul Immunol Inflamm. 2020 Aug 17;28(6):938–946. doi:10.1080/09273948.2019.1641210.
   PubMed Web of Science ®Google Scholar
• Patel KH, Birnbaum AD, Tessler HH, Goldstein DA. Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina. 2011 Jul;31(7):1387–1391. doi:10.1097/IAE.0b013e3182069a8f.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Handa S, Marchese A, et al. Optical coherence tomography findings of underlying choroidal neovascularization in punctate inner choroidopathy. Front Med. Dec 22 2021;8:758370. doi:10.3389/fmed.2021.758370.
   PubMed Web of Science ®Google Scholar
• Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014 Dec;7(1):264. doi:10.1186/1756-0500-7-264.
   PubMedGoogle Scholar
• Nevitt SJ, Marson AG, Davie B, Reynolds S, Williams L, Smith CT. Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review. BMJ . 2017 Apr 5;357:j1390.
   PubMedGoogle Scholar
• Mataftsi A, Haidich AB, Kokkali S, et al. postoperative glaucoma following infantile cataract surgery: an individual patient data meta-analysis. JAMA Ophthalmol. Sep 1 2014;132(9):1059. doi:10.1001/jamaophthalmol.2014.1042.
   PubMed Web of Science ®Google Scholar
• Turkcuoglu P, Chang PY, Rentiya ZS, et al. Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm. Aug 2011;19(4):286–292. doi:10.3109/09273948.2011.580072.
   PubMed Web of Science ®Google Scholar
• Shmueli O, Amer R. Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis. Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):2013–2021. doi:10.1007/s00417-021-05539-9.
   PubMed Web of Science ®Google Scholar
• Minkus CL, Lavine JA, Lee J, Skondra D, Goldstein DA. Use of short-wave blue fundus autofluorescence to detect and monitor acute regional outer retinopathy in punctate inner choroidopathy. Ocul Immunol Inflamm . 2022 May 19;30(4):887–893.
   PubMed Web of Science ®Google Scholar